Pressure BioSciences, Inc. to Present at the Biotech Showcase 2011 and the OneMedPlace Financial Forum 2011 Investor Conferences

SOUTH EASTON, Mass., Jan. 11, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI") today announced that it will present this week at two investor conferences being held in San Francisco, CA: the Biotech Showcase 2011 on Tuesday, January 11th and the OneMedPlace Financial Forum 2011 on Wednesday, January 12th. The Biotech Showcase 2011 will be held at the Parc 55 Wyndham Hotel and the OneMedPlace Financial Forum at the Sir Francis Drake Hotel. Mr. Richard T. Schumacher, PBI President and CEO, will provide a corporate overview at the two presentations. 

About the Biotech Showcase™ 2011

Now in its third year, the Biotech Showcase will feature corporate presentations by approximately 200 innovative life science companies to an audience of public and private investors, business development executives, and professional advisors who are interested in investment opportunities and collaboration. The showcase takes place during the week of one of the most important healthcare investor conferences which annually attracts thousands of healthcare and life science business executives to San Francisco in a venue located close to the center of action. To maximize efficiency, all showcase participants can schedule one-on-one meetings through the organizer's online system, partneringONE™. Public and private investors are always invited to attend the showcase on a complimentary basis. The Biotech Showcase was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life sciences industry. For more information, please visit: www.biotechshowcase.com.

About OneMedPlace Financial Forum 2011  Held annually in San Francisco, the OneMedPlace Financial Forum was created to connect emerging healthcare and life science companies with investors and strategic partners. Over 100 company presentations will occur by some of the most promising - and typically least recognized – companies in the world. Leading investors and experts will discuss the outlook and opportunities for investors and entrepreneurs in multiple areas of health and medicine. The unique OneMedPlace Financial Forum format of sector-oriented panel discussions, company presentations, and investor meetings is designed to connect CEOs with appropriate institutional, venture, and private investors. For more information, please visit: www.onemedforum.com.     About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a NASDAQ Capital Markets listed company focused on the development and sale of instrumentation and consumables based on a novel, enabling technology platform called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 24 issued patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification. PBI currently focuses its efforts on the development and sale of PCT-enhanced bio-molecule extraction and enzymatic digestion products designed specifically for the mass spectrometry marketplace, as well as sample preparation products for biomarker discovery, soil and plant biology, forensics, histology, and counter-bioterror applications.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.  

 Visit us at our website http://www.pressurebiosciences.com

CONTACT: Investor Contacts:
         Richard T. Schumacher, President & CEO
         R. Wayne Fritzsche, Chairman
         Pressure BioSciences, Inc.
         (508) 230-1828 (T)

Released January 11, 2011